News

September 9th, 2014- Featured in the Financial Post: New Technology Puts Your Own Cells to Work to Repair and Rejuvenate Your Body

10 years ago Sep 08, 2014

To read the full report click here: RepliCel’s Cutting-Edge Advancements The following has been published...

September 9th, 2014- RepliCel marches ahead with cell therapy trials

10 years ago Sep 08, 2014

New in BioWorld, the latest in RepliCel’s cell therapy trials and what they could mean...

RepliCel to Present at Rodman & Renshaw’s 16th Annual Global Investment Conference in New York

10 years ago Sep 03, 2014

VANCOUVER, BC – September 4, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP),...

RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium

10 years ago Sep 02, 2014

CCRM and RepliCel to Partner on Development of Cell Therapies for Tendon Repair VANCOUVER, BC...

RepliCel Announces 2014 Second Quarter Financial Results

10 years ago Aug 25, 2014

VANCOUVER, BC – August 26, 2014 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)(TSXV:RP)...

August 7, 2014 – Mark Landy from Summer Street Research Partners Comments on RepliCel in August’s issues of The Life Sciences Report

10 years ago Aug 06, 2014

To read the full report click here: Mark Landy on New Growth Ideas for Biotech...

RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance

10 years ago Jul 15, 2014

VANCOUVER, BC – July 16, 2014 – RepliCel Life Sciences Inc. (the “Company”) (TSXV: RP)...

BioWatch News – RepliCel as a Featured Company in June’s Issue Exploring Alopecia and its Industry

10 years ago Jul 13, 2014

Cell therapies for curing alopecia are early in their clinical development. These must still show...

July 10, 2014 – Alan Leong from BioWatch News Comments on RepliCel in July’s Issues of The Life Sciences Report

10 years ago Jul 09, 2014

For the full article click here: Alan Leong Interview on Niche Biotech Prospects life-scineces-report Read...

RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign

11 years ago Jun 19, 2014

VANCOUVER, BC – June 20, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...

Yahoo Sports Article – RepliCel interviewed on Cristiano Ronaldo’s obscure injury could open door for U.S.

11 years ago Jun 18, 2014

By Martin Rogers June 8, 2014 11:14 PM Yahoo Sports SAO PAULO – To a...

RepliCel Life Sciences Announces Closing of Third and Final Tranche of Private Placement

11 years ago Jun 16, 2014

VANCOUVER, BC – June 17, 2014 – RepliCel Life Sciences Inc. (“RepliCel” or the “Company”)...

RepliCel Retains Christina Cameron as Canadian Investor Relations Consultant

11 years ago Jun 04, 2014

VANCOUVER, BC – June 5, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...

Cell Therapy Group Interview with CEO, David Hall

11 years ago May 26, 2014

Despite us both living in the Vancouver area and both being involved in cell therapy,...

RepliCel Life Sciences Inc. Announces Closing of Second Tranche of Private Placement

11 years ago May 20, 2014

NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES ORDISSEMINATION IN OR INTO THE UNITED STATES...

RepliCel Life Sciences’ Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance RCH-01, a Treatment for Pattern Baldness

11 years ago May 19, 2014

VANCOUVER, BC – May 20, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...

RepliCel Life Sciences Inc. Announces Closing of Brokered and Non-Brokered Private Placement

11 years ago May 08, 2014

NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES ORDISSEMINATION IN OR INTO THE UNITED STATES...

RepliCel Life Sciences Announces Brokered Private Placement

11 years ago Mar 27, 2014

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

RepliCel Reports 2013 Annual Financial Results

11 years ago Mar 17, 2014

VANCOUVER, BC – March 18, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...

RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine

11 years ago Feb 26, 2014

VANCOUVER, BC – February 27, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.